Skip to main content

Table 1 Baseline characteristics of participants enrolled

From: The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial

Variable

Turmeric group (n = 32)

Placebo group

(n = 32)

P value

Age (years)

44.12 ± 8.35

38.56 ± 10.43

0.22

Sex(M/F)

19/13

19/13

1.000α

Smoking

3 (9.3%)

2 (6.25%)

1.000β

Height (cm)

167.84 ± 11.66

167.67 ± 9.15

0.948

Body weight (kg)

82.81 ± 14.37

85.16 ± 18.47

0.572

WC (cm)

104.72 ± 10.71

105.69 ± 15.06

0.768

HC(cm)

110.55 ± 9.10

110.61 ± 10.15

0.979

WHR

0.94 ± 0.04

0.95 ± 0.06

0.722

BMI (kg/m2)

29.51 ± 4.96

30.15 ± 5.10

0.613

SBP (mmHg)

129.00 ± 16.96

124.97 ± 16.97

0.346

DBP (mmHg)

81.84 ± 8.38

81.18 ± 9.38

0.769

Energy (kcal/day)

2199.0 ± 625.2

2059.9 ± 620.2

0.375

Protein (g/day)

91.52 ± 40.87

76.13 ± 24.17

0.072

Fat (g/day)

70.38 ± 32.64

62.46 ± 29.17

0.310

Carbohydrate (g/day)

312.16 ± 11.77

305.52 ± 10.41

0.812

  1. Values presented as mean ± SD
  2. M male, F female, SBP systolic blood pressure, DBP diastolic blood pressure, WC waist circumference, HC hip circumference, WHR waist-to-hip ratio, BMI body mass index
  3. 1Analyzed by Independent t-test
  4. 2Values are presented as mean ± SD
  5. αAnalyzed by Pearson χ2
  6. βAnalyzed by Fisher’s exact-test